CHALLENGES IN THE DIAGNOSIS OF NEUROCYSTICERCOSIS IN DEVELOPING COUNTRIES: A CASE REPORT FROM ZAMBIA AND A REVIEW ON THE ROLE FOR IMMUNODIAGNOSIS.

Victor Mwanakasale, Nataliya Yakovlyeva, Peter Songolo

Abstract


Neurocysticercosis, a complication of Taeniasis solium, is a difficult condition to diagnose. In developing countries that are resource constrained Neurocysticercosis cases either go undetected or are diagnosed late in health facilities that have Computer Tomography scan. A case report on Neurocysticercosis in a female patient from Zambia is presented here. The role of immunodiagnosis in Neurocysticercosis is also reviewed briefly

Keywords


Neurocysticercosis, diagnose, developing countries, immunodiagnosis.

Full Text:

PDF

References


Garcia HH, Nash TE, Dei Brutto OH. “Clinical symptoms, diagnosis, and treatment of neurocysticercosis”. Clinical symptoms, diagnosis, and treatment of neurocysticercosis”. Lancet Neurol. (2014): 43; 1202-1215.

Garcia Hector H, On’Neal Seath E, Hoh John, Handati Sukwan for the Cysticercosis working group in Peru. “Laboratory diagnosis of Neurocysticercosis (Tanie solium)”. Journal of Clinical Microbiology. (2018): 56(9), e00424.

Newton CR, Garcia HH. “Epilepsy in poor regions of the world”. Lancet. (2012): 380; 1193-1201.

Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, Rainwater E, Dickey M, Reynolds S, Stoner JA. “A systematic review of the frequency of neurocysticercosis with a focus on people with epilepsy”. PLoS Neglected Trop Dis. (2010): 4; e870.doi:10.137/journal.

Dixon HB and Lipscomb FM. ”Cysticercosis: an analysis and follow-up of 450 cases”. Medical Research Council, London, United Kingdom. (1961), Vol 299.

Prabhakhar S and Singh G. “Taenia solium: a historical note”., in Singh G and Prabhakhar S (ed), Taenia solium cysticercosis; from basic to clinical science, CABI Publishing, oxon, United Kingdom (2002). 157-168.

Tsang VC, Brand JA, Boyer AE. “An Enzyme-Linked Immunelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J.Infect Dis (1989) 159: 50-59.

Arambulo PV, Wallis KW, Bullock S, Kagan IG. “Serodiagnosis of human cysticercosis by microplate enzyme-linked immunospecific assay (ELISA)”. Acta Trop. (1978) 35:63-67.

Coker-Vann M, Brown P, Gajdusek DC. “Serodiagnosis of human cysticercosis using a chromatofocused antigenic preparation of Taenia solium cysticerci in an enzyme-linked immunosorbent assay (ELISA)”. Trans R. Soc Trop. Med Hyg. (1984) 78: 492-498.

Diwan AR, Coker-Vann M, Brown P, Subianto DB, Yolken R, Desowitz R, Escobar A, Gibbs CJ Jr, Gajdusek DC. “Enzyme-linked Immunosorbent assay (ELISA) for the detection of antibody to cysticerci of Taenia solium”. Am. J. Trop Med Hyg (1982) 31: 364-369.

Costa JM, Ferreira AW, Makino MM, Camango ME. “Spinal fluid Immunoenymatic assay (ELISA) for Neurocysticercosis”. Rev. Inst Med Trop. Sao Paulo.(1982) 24: 337-341.

Tellez Giron E, Ramos MC, Dufour L, Montante M. “Use of the ELISA method in the diagnosis of cysticercosis”. Bol Officina Sanit Panam (1984) 97: 8-13.

Correa D, Sandoval MA, Harrison LJ, Parkhouse RM, Plancarte A, Meza-Lucas A, Fisser A. “Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebralspinal fluid”. Trans R. Soc Trop Hyg (1989) 83: 814-816.

Rodriguez S, Wilkins P, Domy P. “Immunological and molecular diagnosis of cysticercosis”. Pathog Glob Health (2012) 106: 286-298.


Refbacks

  • There are currently no refbacks.